Predictors of ventricular tachyarrhythmia in patients with a wearable cardioverter defibrillator: an international multicenter registry.
Fabienne KreimerKatharina KoepselMichael GotzmannBoldizsar KovacsTobias C DreherChristian BlockhausNorbert KleinThomas KuntzDong-In ShinHendrik LappStephanie RosenkaimerMohammad AbumayyalehNazha HamdaniArdan Muammer SagunerJulia W ErathFirat DuruThomas BeiertFabian SchiedatChristian WethFlorian CustodisIbrahim AkinAndreas MüggeAssem AweimerIbrahim El-BattrawyPublished in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2024)
Patients who received WCD due to a transient increased risk of sudden cardiac death have a comparatively lower risk of VT/VF in the presence of non-ischemic cardiomyopathy. Of note, optimal medical treatment for heart failure not only results in an improvement in left ventricular ejection fraction but also in a reduction in the risk for VT/VF.
Keyphrases
- heart failure
- ejection fraction
- left ventricular
- aortic stenosis
- cardiac resynchronization therapy
- cerebral ischemia
- hypertrophic cardiomyopathy
- healthcare
- acute myocardial infarction
- left atrial
- acute heart failure
- mitral valve
- atrial fibrillation
- transcatheter aortic valve replacement
- clinical trial
- ischemia reperfusion injury
- heart rate
- combination therapy
- subarachnoid hemorrhage
- coronary artery disease
- double blind
- brain injury
- smoking cessation
- replacement therapy